8 am – 8:20 am The use of exogenous hormones and breast cancer. What is the evidence? Where are we headed?
Ruth Helena de Morais Bonini (BRA)
8:40 am – 9 am Challenges in attempts at breast conservation. How far can we go? Does a multifocal/multicentric disease equals mastectomy? LCIS and lesions that indicate high risk margins. What to do?
Jose Pereira Guará (BRA)
9 am - 9:20 am Challenges in the diagnosis of invasive lobular carcinoma of the breast
Felipe Pereira Zerwes (BRA)
9:20 am – 9:40 am Closing the wall in large resections
Vilmar Marques de Oliveira (BRA)
9:40 am – 10 am Discussion
10 am – 10:30 am Coffee Break
PART 2
10:30 am – 12 pm
10:30 am – 10:50 am Advances in PET CT:FDG for staging? FES in disease progression?
Whemberton Martins de Araújo (BRA)
10:50 am - 11:10 am Non-invasive Lobular Neoplasia (ALH/LCIS) and Non-Classical Variants: Differential Diagnosis and Clinical Implications
Maria do Carmo Abreu (BRA)
11:10 am - 11:30 am How to estimate the benefits of preventive surgery in cancer patients with patogenic mutations, in moderate and high penetrance genes
